Skip to main content

Table 4 Univariate and multivariate Cox proportional hazards regression analyses for overall survival of uterine sarcoma patients (n =112)

From: Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study

Parameter

Univariate analysis

Multivariate analysis

HR (95%CI)

P-value

HR (95%CI

P-value

Histological types

 

<0.001

 

<0.001

 AS(N=10)

1 (referent)

 

1 (referent)

 

 ULMS(N=41)

9.450 (1.095-81.920)

0.041

10.485(1.170-93.928)

0.036

 LG-ESS(N=43)

1.459(0.156-13.693)

0.741

2.371(0.255-22.050)

0.448

 HG-ESS(N=13)

99.000(5402-1814.474)

0.002

38.355(3.881-379.020)

0.002

 UUS(N=5)

36.000(1.772-731.562)

0.020

47.622(4.315-525.554)

0.002

FIGO stage

 Stage I

1 (referent)

   

 Stage II-IV

1.498(0.530-4.240)

0.446

  

Lymphadenectomy

 Yes

1 (referent)

   

 No

1.619(0.620-4.227)

0.852

  

Initial surgery

 Laparotomy

1 (referent)

   

 Laparoscopy

1.508(0.684-3.327)

0.309

  

Ovariectomy

 Yes

1 (referent)

   

  No

0.632(0.233-1.713)

0.325

  

Age(years)

 ≤50

1 (referent)

   

 >50

1.496(0.688-3.250)

0.309

  

Size

 ≤7.5

1 (referent)

 

1 (referent)

 

 >7.5

2.190(0.999-4.801)

0.050

2.277(1.157-4.484)

0.017

Menstrual status

 Premenopausal

1 (referent)

   

 Postmenopausal

2.250 (0.990-5.116)

0.053

  

NLR

 ≤2.14

1 (referent)

 

1 (referent)

 

 >2.14

3.666(1.484-9.054)

0.005

2.026(0.919-4.468)

0.080

PLR

 ≤128.5

1 (referent)

   

 >128.5

4.705(1.642-13.484)

0.004

  
  1. Abbreviations: AS Adenosarcoma, ULMS Uterine leiomyosarcoma, LG-ESS Low-grade endometrial stromal sarcoma, HG-ESS High-grade endometrial stromal sarcoma, UUS Undifferentiated uterine sarcoma, NLR Neutrophil to lymphocyte ratio, PLR Platelet to lymphocyte ratio, HR Hazard ratio, CI Confidence interval